The efficacy of corticosteroid-sparing immunomodulatory therapy in treating patients with central multifocal choroiditis.
Evianne L de GrootNinette H Ten Dam-van LoonJoke H de BoerJeannette Ossewaarde-van NorelPublished in: Acta ophthalmologica (2020)
Preventive therapy with IMT should be considered in patients with recurrent and/or sight-threatening MFC to decrease the number of recurrences/year and to increase the prospects of achieving either remission or steroid-free remission.